Healthcare Analytics Market by Type (Predictive, Diagnostic), Application (Claim, RCM, Fraud, Precision Health, RWE, Imaging, Supply Chain, Workforce, Population Health), EndUser (Payer, Hospital, ACO, ASC, Govt, Clinic), Region: Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES
• 1.7 IMPACT OF AI/GEN AI

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Insights from primary experts
• 2.2 RESEARCH METHODOLOGY DESIGN
• 2.3 MARKET SIZE ESTIMATION METHODOLOGY
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW
• 4.2 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SHARE, BY END USER AND COUNTRY (2023)
• 4.3 HEALTHCARE ANALYTICS MARKET, BY COUNTRY
• 4.4 HEALTHCARE ANALYTICS MARKET: REGIONAL MIX
• 4.5 HEALTHCARE ANALYTICS MARKET: EMERGING ECONOMIES VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Favorable government initiatives for electronic health record adoption
    • 5.2.1.2 Growing venture capital investments in startups
    • 5.2.1.3 Need to reduce healthcare costs
    • 5.2.1.4 Increasing focus on real-world evidence
    • 5.2.1.5 Rise of telemedicine and remote patient monitoring
    • 5.2.1.6 Growing focus on regulatory compliance
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of analytics solutions
    • 5.2.2.2 Growing concerns about data breach
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing focus on value-based medicines
    • 5.2.3.2 Growing use of analytics in healthcare
    • 5.2.3.3 Rising number of patient registries
    • 5.2.3.4 Emergence of social media and digital health technologies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Concerns regarding inaccurate and inconsistent data
    • 5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
    • 5.2.4.3 Lack of maintenance of medical records
    • 5.2.4.4 Shortage of skilled personnel
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.4 INDUSTRY TRENDS
  • 5.4.1 INCREASING PARTNERSHIPS AND COLLABORATIONS AMONG MARKET PLAYERS
  • 5.4.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
  • 5.4.3 GROWING ADOPTION OF CLOUD-BASED IT SOLUTIONS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 TECHNOLOGY ANALYSIS
  • 5.7.1 KEY TECHNOLOGIES
    • 5.7.1.1 Big data analytics
    • 5.7.1.2 Artificial intelligence and machine learning
    • 5.7.1.3 Business intelligence tools
  • 5.7.2 ADJACENT TECHNOLOGIES
    • 5.7.2.1 Cloud computing
    • 5.7.2.2 Internet of things
• 5.8 REGULATORY LANDSCAPE
  • 5.8.1 REGULATORY ANALYSIS
  • 5.8.2 GOVERNMENT REGULATIONS
    • 5.8.2.1 US
    • 5.8.2.2 Europe
    • 5.8.2.3 China
    • 5.8.2.4 Japan
    • 5.8.2.5 India
  • 5.8.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
  • 5.9.2 AVERAGE SELLING PRICE, BY REGION
• 5.10 PORTER'S FIVE FORCES ANALYSIS
• 5.11 PATENT ANALYSIS
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.12.2 BUYING CRITERIA
• 5.13 END-USER ANALYSIS
  • 5.13.1 UNMET NEEDS
  • 5.13.2 END-USER EXPECTATIONS
• 5.14 KEY CONFERENCES AND EVENTS, 2024-2025
• 5.15 CASE STUDY ANALYSIS
• 5.16 BUSINESS MODEL ANALYSIS
• 5.17 INVESTMENT AND FUNDING SCENARIO
• 5.18 IMPACT OF AI/GEN AI ON HEALTHCARE ANALYTICS MARKET
  • 5.18.1 KEY USE CASES
  • 5.18.2 CASE STUDY ON AI/GEN AI
  • 5.18.3 ADJACENT MARKET ECOSYSTEM
    • 5.18.3.1 Life science analytics market
    • 5.18.3.2 Healthcare IT market
    • 5.18.3.3 Healthcare fraud analytics market
  • 5.18.4 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.4.1 User readiness
      • 5.18.4.1.1 Payers
      • 5.18.4.1.2 Providers
    • 5.18.4.2 Impact assessment
      • 5.18.4.2.1 User A: Payers
        • 5.18.4.2.1.1 Implementation
        • 5.18.4.2.1.2 Impact
      • 5.18.4.2.2 User B: Providers
        • 5.18.4.2.2.1 Implementation
        • 5.18.4.2.2.2 Impact

6 HEALTHCARE ANALYTICS MARKET, BY COMPONENT

• 6.1 INTRODUCTION
• 6.2 SERVICES
  • 6.2.1 MANAGED SERVICES
    • 6.2.1.1 Analytical services
      • 6.2.1.1.1 Increasing volume of healthcare data to facilitate growth
    • 6.2.1.2 Consulting services
      • 6.2.1.2.1 Need to improve clinical outcomes and patient satisfaction to support growth
  • 6.2.2 PROFESSIONAL SERVICES
    • 6.2.2.1 Training & implementation services
      • 6.2.2.1.1 Growing emphasis on value-based care and specialized training services to drive market
    • 6.2.2.2 Maintenance & support services
      • 6.2.2.2.1 Expanding research needs to propel demand for maintenance & support services
• 6.3 SOFTWARE
  • 6.3.1 ON-PREMISE SOFTWARE
    • 6.3.1.1 Provision of multi-vendor architecture and security benefits to drive market
  • 6.3.2 CLOUD-BASED SOFTWARE
    • 6.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption

7 HEALTHCARE ANALYTICS MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 DESCRIPTIVE ANALYTICS
  • 7.2.1 INCREASING USE IN PATIENT POPULATION MANAGEMENT AND FINANCIAL MANAGEMENT TO BOOST MARKET
• 7.3 PREDICTIVE ANALYTICS
  • 7.3.1 ABILITY OF PREDICTIVE ANALYTICS TO HELP HEALTHCARE ORGANIZATIONS AVOID PREVENTABLE EVENTS TO SUPPORT GROWTH
• 7.4 PRESCRIPTIVE ANALYTICS
  • 7.4.1 NEED FOR BETTER TREATMENT METHODS AND BUSINESS PRACTICES TO ENCOURAGE GROWTH
• 7.5 DIAGNOSTIC ANALYTICS
  • 7.5.1 RISE IN LAUNCHES OF AI-DRIVEN ANALYTICS PRODUCTS AND SERVICES TO EXPEDITE GROWTH

8 HEALTHCARE ANALYTICS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 FINANCIAL ANALYTICS
  • 8.2.1 CLAIMS PROCESSING
    • 8.2.1.1 Increasing shift from paper-based claims processing to electronic mode to augment growth
  • 8.2.2 REVENUE CYCLE MANAGEMENT
    • 8.2.2.1 Growing focus on financial forecasting and budgeting process to boost market
  • 8.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE
    • 8.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to drive market
  • 8.2.4 RISK ADJUSTMENT & ASSESSMENT
    • 8.2.4.1 Rise in special enrollment periods and new subsidies to accelerate growth
• 8.3 CLINICAL ANALYTICS
  • 8.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
    • 8.3.1.1 Growing adoption of benchmarking to identify negative issues impacting healthcare systems to drive market
  • 8.3.2 CLINICAL DECISION SUPPORT
    • 8.3.2.1 Need to reduce medical errors and expedite diagnosis to boost market
  • 8.3.3 REPORTING & COMPLIANCE
    • 8.3.3.1 Ability to track regulatory changes, assess non-compliance, and perform internal audits to sustain growth
  • 8.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
    • 8.3.4.1 Growing adoption of electronic health records to fuel market
  • 8.3.5 PRECISION HEALTH/REAL-WORLD EVIDENCE
    • 8.3.5.1 Strong government support for personalized medicine to sustain growth
  • 8.3.6 MEDICAL IMAGING ANALYTICS
    • 8.3.6.1 Ability to provide real-time insights and diagnosis of genetic disorders to aid growth
• 8.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS
  • 8.4.1 SUPPLY CHAIN ANALYTICS
    • 8.4.1.1 Growing need to reduce healthcare costs and implement better inventory management practices to fuel market
  • 8.4.2 WORKFORCE ANALYTICS
    • 8.4.2.1 Need for effective recruitment to favor growth
  • 8.4.3 STRATEGIC ANALYTICS
    • 8.4.3.1 Growing use of advanced analytics tools for geographic expansion and service line expansion to drive market
• 8.5 POPULATION HEALTH ANALYTICS
  • 8.5.1 RISING USE IN CLINICAL OUTCOME ENGAGEMENT AND POPULATION RISK MANAGEMENT TO SPUR GROWTH

9 HEALTHCARE ANALYTICS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 PAYERS
  • 9.2.1 PRIVATE INSURANCE COMPANIES
    • 9.2.1.1 Increasing reliance on analytics for fraud prevention and claims processing to contribute to growth
  • 9.2.2 GOVERNMENT AGENCIES
    • 9.2.2.1 Rising use of analytics solutions to maximize payment accuracy and set reimbursement rates to boost market
• 9.3 PROVIDERS
  • 9.3.1 HOSPITALS & CLINICS
    • 9.3.1.1 Growing adoption of healthcare analytics solutions by large hospitals, medical groups, and physician practices to boost market
  • 9.3.2 POST-ACUTE CARE ORGANIZATIONS
    • 9.3.2.1 Increasing use of analytics solutions to review and study patient data to drive market
  • 9.3.3 AMBULATORY SURGERY CENTERS
    • 9.3.3.1 Need to control healthcare costs to support market
  • 9.3.4 OTHER PROVIDERS
• 9.4 PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN
  • 9.4.1 MANUFACTURERS
    • 9.4.1.1 Growing adoption of digital technologies to drive market
  • 9.4.2 DISTRIBUTORS & WHOLESALERS
    • 9.4.2.1 Need for improved supply chain operations, inventory management, and service delivery to boost market
  • 9.4.3 RETAILERS
    • 9.4.3.1 Rising integration of healthcare analytics into retail operations to stimulate growth

10 HEALTHCARE ANALYTICS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 High adoption of electronic health records to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Need for managing patient volumes, clinical data, and healthcare costs to favor market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Government initiatives to increase use of analytics in healthcare
  • 10.3.3 UK
    • 10.3.3.1 Availability of venture capital investments to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Strong financial support for digital health to augment market
  • 10.3.5 ITALY
    • 10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing adoption of personalized medicine to drive market
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 JAPAN
    • 10.4.2.1 Rising geriatric population to drive demand for effective patient management solutions
  • 10.4.3 CHINA
    • 10.4.3.1 Favorable reforms and growing number of electronic health records to aid growth
  • 10.4.4 INDIA
    • 10.4.4.1 Favorable government initiatives to fuel market
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Growing adoption of digital solutions in healthcare to boost market
  • 10.5.3 MEXICO
    • 10.5.3.1 Growing prominence of startups and rising R&D activity to propel market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2024
• 11.3 REVENUE ANALYSIS, 2019-2023
• 11.4 MARKET SHARE ANALYSIS, 2023
• 11.5 COMPANY EVALUATION AND FINANCIAL METRICS
• 11.6 BRAND/SOFTWARE COMPARISON
• 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 11.7.1 STARS
  • 11.7.2 EMERGING LEADERS
  • 11.7.3 PERVASIVE PLAYERS
  • 11.7.4 PARTICIPANTS
  • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 11.7.5.1 Company footprint
    • 11.7.5.2 Region footprint
    • 11.7.5.3 Component footprint
    • 11.7.5.4 Application footprint
    • 11.7.5.5 End-user footprint
• 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 11.8.1 PROGRESSIVE COMPANIES
  • 11.8.2 RESPONSIVE COMPANIES
  • 11.8.3 DYNAMIC COMPANIES
  • 11.8.4 STARTING BLOCKS
  • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • 11.8.5.1 Detailed list of key startups/SMEs
    • 11.8.5.2 Competitive benchmarking of key startups/SMEs
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 MERATIVE
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products/Solutions/Services offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.1.3.2 Deals
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 SAS INSTITUTE INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products/Solutions/Services offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 OPTUM, INC.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products/Solutions/Services offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 ORACLE
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products/Solutions/Services offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.4.3.2 Deals
      • 12.1.4.3.3 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 VERADIGM LLC
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products/Solutions/Services offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.5.3.2 Deals
      • 12.1.5.3.3 Expansions
      • 12.1.5.3.4 Other developments
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 EXLSERVICE HOLDINGS, INC.
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products/Solutions/Services offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.6.3.2 Deals
      • 12.1.6.3.3 Other developments
  • 12.1.7 CITIUSTECH INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products/Solutions/Services offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.7.3.2 Deals
      • 12.1.7.3.3 Expansions
      • 12.1.7.3.4 Other developments
  • 12.1.8 HEALTH CATALYST
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products/Solutions/Services offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.8.3.2 Deals
  • 12.1.9 CVS HEALTH
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products/Solutions/Services offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
  • 12.1.10 INOVALON
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products/Solutions/Services offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.10.3.2 Deals
      • 12.1.10.3.3 Expansions
      • 12.1.10.3.4 Other developments
  • 12.1.11 MCKESSON CORPORATION
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products/Solutions/Services offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Deals
  • 12.1.12 MEDEANALYTICS, INC.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products/Solutions/Services offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
      • 12.1.12.3.2 Other developments
  • 12.1.13 COTIVITI, INC.
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products/Solutions/Services offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.13.3.2 Other developments
  • 12.1.14 APIXIO, INC.
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products/Solutions/Services offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.14.3.2 Deals
  • 12.1.15 ENLITIC
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products/Solutions/Services offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.15.3.2 Deals
  • 12.1.16 KOMODO HEALTH, INC.
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products/Solutions/Services offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product/Solution Launches/Enhancements/Approvals/ Upgrades
      • 12.1.16.3.2 Deals
  • 12.1.17 HEALTHEC, LLC
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products/Solutions/Services offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Deals
  • 12.1.18 IQVIA
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products/Solutions/Services offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Deals
  • 12.1.19 WIPRO
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products/Solutions/Services offered
• 12.2 OTHER PLAYERS
  • 12.2.1 ARCADIA SOLUTIONS, LLC.
  • 12.2.2 EVIDATION HEALTH, INC.
  • 12.2.3 HEALTHCORUM
  • 12.2.4 AETION, INC.
  • 12.2.5 TREDENCE.INC.
  • 12.2.6 SISENSE LTD.

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS

List of Tables

• TABLE 1 HEALTHCARE ANALYTICS MARKET: INCLUSIONS AND EXCLUSIONS
• TABLE 2 HEALTHCARE ANALYTICS MARKET: RESEARCH ASSUMPTIONS
• TABLE 3 HEALTHCARE ANALYTICS MARKET: RISK ASSESSMENT
• TABLE 4 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2023
• TABLE 5 HEALTHCARE ANALYTICS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
• TABLE 6 NORTH AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
• TABLE 7 EUROPE: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
• TABLE 8 ASIA PACIFIC: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
• TABLE 9 MIDDLE EAST & AFRICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
• TABLE 10 LATIN AMERICA: REGULATIONS GOVERNING HEALTHCARE ANALYTICS MARKET
• TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 16 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT
• TABLE 17 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION
• TABLE 18 HEALTHCARE ANALYTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 19 HEALTHCARE ANALYTICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2020-2023
• TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USER (%)
• TABLE 21 KEY BUYING CRITERIA FOR END USER
• TABLE 22 UNMET NEEDS IN HEALTHCARE ANALYTICS MARKET
• TABLE 23 END-USER EXPECTATIONS IN HEALTHCARE ANALYTICS MARKET
• TABLE 24 HEALTHCARE ANALYTICS MARKET: KEY CONFERENCES AND EVENTS, 2024-2025
• TABLE 25 ADOPTION OF HEALTH CATALYST DATA OPERATING SYSTEM FOR IMPROVED ANNUAL SAVINGS
• TABLE 26 USE OF COMPREHENSIVE DATA ANALYTICS PLATFORM TO MEET NEEDS OF EVOLVING HEALTHCARE ENVIRONMENT
• TABLE 27 ENHANCED CLINICAL DECISION-MAKING PROCESS WITH DATA OPERATING SYSTEM PLATFORM
• TABLE 28 ENHANCED PATIENT OUTCOMES WITH AI-DRIVEN PREDICTIVE ANALYTICS
• TABLE 29 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 30 HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 31 HEALTHCARE ANALYTICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 32 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 33 HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 34 HEALTHCARE ANALYTICS MARKET FOR ANALYTICAL SERVICES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 35 HEALTHCARE ANALYTICS MARKET FOR CONSULTING SERVICES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 36 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 37 HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 38 HEALTHCARE ANALYTICS MARKET FOR TRAINING & IMPLEMENTATION SERVICES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 39 HEALTHCARE ANALYTICS MARKET FOR MAINTENANCE & SUPPORT SERVICES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 40 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 41 HEALTHCARE ANALYTICS SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 42 HEALTHCARE ANALYTICS MARKET FOR ON-PREMISE SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
• TABLE 43 HEALTHCARE ANALYTICS MARKET FOR CLOUD-BASED SOFTWARE, BY REGION, 2022-2029 (USD MILLION)
• TABLE 44 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 45 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 46 APPLICATIONS OF PREDICTIVE ANALYTICS
• TABLE 47 COMMERCIALLY AVAILABLE PREDICTIVE ANALYTICS SOLUTIONS
• TABLE 48 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 49 COMMERCIALLY AVAILABLE PRESCRIPTIVE ANALYTICS SOLUTIONS
• TABLE 50 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 51 DIAGNOSTIC ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 52 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 53 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
• TABLE 54 FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 55 FINANCIAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 56 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
• TABLE 57 FINANCIAL ANALYTICS MARKET FOR CLAIMS PROCESSING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS
• TABLE 59 FINANCIAL ANALYTICS MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2022-2029 (USD MILLION)
• TABLE 60 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
• TABLE 61 FINANCIAL ANALYTICS MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2022-2029 (USD MILLION)
• TABLE 62 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
• TABLE 63 FINANCIAL ANALYTICS MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2022-2029 (USD MILLION)
• TABLE 64 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
• TABLE 65 CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 66 CLINICAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 67 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
• TABLE 68 CLINICAL ANALYTICS MARKET FOR QUALITY IMPROVEMENT & CLINICAL BENCHMARKING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 69 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT
• TABLE 70 CLINICAL ANALYTICS MARKET FOR CLINICAL DECISION SUPPORT, BY REGION, 2022-2029 (USD MILLION)
• TABLE 71 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE
• TABLE 72 CLINICAL ANALYTICS MARKET FOR REPORTING & COMPLIANCE, BY REGION, 2022-2029 (USD MILLION)
• TABLE 73 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS
• TABLE 74 CLINICAL ANALYTICS MARKET FOR COMPARATIVE ANALYTICS/EFFECTIVENESS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 75 COMMERCIALLY AVAILABLE PRECISION HEALTH/REAL-WORLD EVIDENCE SOLUTIONS
• TABLE 76 CLINICAL ANALYTICS MARKET FOR PRECISION HEALTH/REAL-WORLD EVIDENCE, BY REGION, 2022-2029 (USD MILLION)
• TABLE 77 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS
• TABLE 78 CLINICAL ANALYTICS MARKET FOR MEDICAL IMAGING ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 79 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
• TABLE 80 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 81 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 82 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
• TABLE 83 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 84 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
• TABLE 85 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR WORKFORCE ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 86 OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET FOR STRATEGIC ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 87 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
• TABLE 88 POPULATION HEALTH ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 89 HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 90 COMMERCIALLY AVAILABLE SOLUTIONS FOR HEALTHCARE PAYERS
• TABLE 91 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 92 HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 93 HEALTHCARE ANALYTICS MARKET FOR PRIVATE INSURANCE COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 94 HEALTHCARE ANALYTICS MARKET FOR GOVERNMENT AGENCIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 95 COMMERCIALLY AVAILABLE ANALYTICS SOLUTIONS FOR HEALTHCARE PROVIDERS
• TABLE 96 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 97 HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 98 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR HOSPITALS & CLINICS
• TABLE 99 HEALTHCARE ANALYTICS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 100 HEALTHCARE ANALYTICS MARKET FOR POST-ACUTE CARE ORGANIZATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 101 COMMERCIALLY AVAILABLE HEALTHCARE ANALYTICS SOLUTIONS FOR AMBULATORY SURGERY CENTERS
• TABLE 102 HEALTHCARE ANALYTICS MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 103 COMMERCIALLY AVAILABLE SOLUTIONS FOR ACCOUNTABLE CARE ORGANIZATIONS
• TABLE 104 HEALTHCARE ANALYTICS MARKET FOR OTHER PROVIDERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 105 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 106 HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY REGION, 2022-2029 (USD MILLION)
• TABLE 107 HEALTHCARE ANALYTICS MARKET FOR MANUFACTURERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 108 HEALTHCARE ANALYTICS MARKET FOR DISTRIBUTORS & WHOLESALERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 109 HEALTHCARE ANALYTICS MARKET FOR RETAILERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 110 HEALTHCARE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 111 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 112 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 113 NORTH AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 114 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 115 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 116 NORTH AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 117 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 118 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 119 NORTH AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 120 NORTH AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 121 NORTH AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 122 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 123 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 124 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 125 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 126 US: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 127 US: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 128 US: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 129 US: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 130 US: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 131 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 132 US: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 133 US: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 134 US: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 135 US: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 136 US: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 137 US: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 138 US: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 139 US: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 140 CANADA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 141 CANADA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 142 CANADA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 143 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 144 CANADA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 145 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 146 CANADA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 147 CANADA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 148 CANADA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 149 CANADA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 150 CANADA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 151 CANADA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 152 CANADA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 153 CANADA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 154 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 155 EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 156 EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 157 EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 158 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 159 EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 160 EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 161 EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 162 EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 163 EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 164 EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 165 EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 166 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 167 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 168 EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 169 GERMANY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 170 GERMANY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 171 GERMANY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 172 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 173 GERMANY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 174 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 175 GERMANY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 176 GERMANY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 177 GERMANY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 178 GERMANY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 179 GERMANY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 180 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 181 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 182 GERMANY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 183 UK: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 184 UK: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 185 UK: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 186 UK: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 187 UK: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 188 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 189 UK: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 190 UK: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 191 UK: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 192 UK: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 193 UK: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 194 UK: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 195 UK: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 196 UK: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 197 FRANCE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 198 FRANCE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 199 FRANCE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 200 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 201 FRANCE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 202 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 203 FRANCE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 204 FRANCE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 205 FRANCE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 206 FRANCE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 207 FRANCE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 208 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 209 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 210 FRANCE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 211 ITALY: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 212 ITALY: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 213 ITALY: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 214 ITALY: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 215 ITALY: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 216 ITALY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 217 ITALY: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 218 ITALY: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 219 ITALY: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 220 ITALY: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 221 ITALY: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 222 ITALY: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 223 ITALY: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 224 ITALY: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 225 SPAIN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 226 SPAIN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 227 SPAIN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 228 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 229 SPAIN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 230 SPAIN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 231 SPAIN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 232 SPAIN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 233 SPAIN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 234 SPAIN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 235 SPAIN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 236 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 237 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 238 SPAIN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 239 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 240 REST OF EUROPE: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 241 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 242 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 243 REST OF EUROPE: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 244 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 245 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 246 REST OF EUROPE: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 247 REST OF EUROPE: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 248 REST OF EUROPE: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 249 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 250 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 251 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 252 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 253 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 254 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 255 ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 256 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 257 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 258 ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 259 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 260 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 261 ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 262 ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 263 ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 264 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 265 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 266 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 267 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 268 JAPAN: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 269 JAPAN: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 270 JAPAN: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 271 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 272 JAPAN: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 273 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 274 JAPAN: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 275 JAPAN: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 276 JAPAN: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 277 JAPAN: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 278 JAPAN: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 279 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 280 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 281 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 282 CHINA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 283 CHINA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 284 CHINA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 285 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 286 CHINA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 287 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 288 CHINA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 289 CHINA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 290 CHINA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 291 CHINA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 292 CHINA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 293 CHINA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 294 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 295 CHINA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 296 INDIA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 297 INDIA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 298 INDIA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 299 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 300 INDIA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 301 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 302 INDIA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 303 INDIA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 304 INDIA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 305 INDIA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 306 INDIA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 307 INDIA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 308 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 309 INDIA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 310 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 311 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 312 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 313 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 314 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 315 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 316 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 317 REST OF ASIA PACIFIC: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 318 REST OF ASIA PACIFIC: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 319 REST OF ASIA PACIFIC: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 320 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 321 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 322 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 323 REST OF ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 324 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 325 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 326 LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 327 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 328 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 329 LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 330 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 331 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 332 LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 333 LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 334 LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 335 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 336 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 337 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 338 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 339 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 340 BRAZIL: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 341 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 342 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 343 BRAZIL: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 344 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 345 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 346 BRAZIL: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 347 BRAZIL: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 348 BRAZIL: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 349 BRAZIL: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 350 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 351 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 352 BRAZIL: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 353 MEXICO: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 354 MEXICO: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 355 MEXICO: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 356 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 357 MEXICO: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 358 MEXICO: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 359 MEXICO: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 360 MEXICO: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 361 MEXICO: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 362 MEXICO: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 363 MEXICO: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 364 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 365 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 366 MEXICO: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 367 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 368 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 369 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 370 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 371 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 372 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 373 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 374 REST OF LATIN AMERICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 375 REST OF LATIN AMERICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 376 REST OF LATIN AMERICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 377 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 378 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 379 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 380 REST OF LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 381 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 382 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 383 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 384 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 385 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 386 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 387 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 388 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 389 MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 390 MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 391 MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 392 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 393 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 394 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 395 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 396 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 397 GCC COUNTRIES: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 398 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 399 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 400 GCC COUNTRIES: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 401 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 402 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 403 GCC COUNTRIES: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 404 GCC COUNTRIES: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 405 GCC COUNTRIES: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 406 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 407 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 408 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 409 GCC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 410 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
• TABLE 411 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 412 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR MANAGED SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 413 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROFESSIONAL SERVICES, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 414 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 415 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 416 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 417 REST OF MIDDLE EAST & AFRICA: FINANCIAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 418 REST OF MIDDLE EAST & AFRICA: CLINICAL ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 419 REST OF MIDDLE EAST & AFRICA: OPERATIONAL & ADMINISTRATIVE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 420 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 421 REST OF MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET FOR PAYERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 422 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 423 REST OF MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PHARMACEUTICAL & MEDICAL DEVICE SUPPLY CHAIN, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 424 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET, 2021-2024
• TABLE 425 HEALTHCARE ANALYTICS MARKET: DEGREE OF COMPETITION
• TABLE 426 HEALTHCARE ANALYTICS MARKET: REGION FOOTPRINT
• TABLE 427 HEALTHCARE ANALYTICS MARKET: COMPONENT FOOTPRINT
• TABLE 428 HEALTHCARE ANALYTICS MARKET: APPLICATION FOOTPRINT
• TABLE 429 HEALTHCARE ANALYTICS MARKET: END-USER FOOTPRINT
• TABLE 430 HEALTHCARE ANALYTICS MARKET: KEY STARTUPS/SMES
• TABLE 431 HEALTHCARE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
• TABLE 432 HEALTHCARE ANALYTICS MARKET: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 433 HEALTHCARE ANALYTICS MARKET: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 434 HEALTHCARE ANALYTICS MARKET: EXPANSIONS, JANUARY 2021-OCTOBER 2024
• TABLE 435 MERATIVE: COMPANY OVERVIEW
• TABLE 436 MERATIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 437 MERATIVE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 438 MERATIVE: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 439 SAS INSTITUTE INC.: COMPANY OVERVIEW
• TABLE 440 SAS INSTITUTE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 441 SAS INSTITUTE INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 442 OPTUM, INC.: COMPANY OVERVIEW
• TABLE 443 OPTUM, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 444 OPTUM, INC.: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 445 ORACLE: COMPANY OVERVIEW
• TABLE 446 ORACLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 447 ORACLE: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 448 ORACLE: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 449 ORACLE: EXPANSIONS, JANUARY 2021-OCTOBER 2024
• TABLE 450 VERADIGM LLC: COMPANY OVERVIEW
• TABLE 451 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 452 VERADIGM LLC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 453 VERADIGM LLC: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 454 VERADIGM LLC: EXPANSIONS, JANUARY 2021-OCTOBER 2024
• TABLE 455 VERADIGM LLC: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 456 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
• TABLE 457 EXLSERVICE HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 458 EXLSERVICE HOLDINGS, INC.: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/ APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 459 EXLSERVICE HOLDINGS, INC.: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 460 EXLSERVICE HOLDINGS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 461 CITIUSTECH INC.: COMPANY OVERVIEW
• TABLE 462 CITIUSTECH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 463 CITIUSTECH INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 464 CITIUSTECH INC.: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 465 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 466 CITIUSTECH INC.: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 467 HEALTH CATALYST: COMPANY OVERVIEW
• TABLE 468 HEALTH CATALYST: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 469 HEALTH CATALYST: PRODUCT SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 470 HEALTH CATALYST: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 471 CVS HEALTH: COMPANY OVERVIEW
• TABLE 472 CVS HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 473 CVS HEALTH: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 474 INOVALON: COMPANY OVERVIEW
• TABLE 475 INOVALON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 476 INOVALON: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 477 INOVALON: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 478 INOVALON: EXPANSIONS, JANUARY 2021-OCTOBER 2024
• TABLE 479 INOVALON: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 480 MCKESSON CORPORATION: COMPANY OVERVIEW
• TABLE 481 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 482 MCKESSON CORPORATION: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 483 MEDEANALYTICS, INC.: COMPANY OVERVIEW
• TABLE 484 MEDEANALYTICS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 485 MEDEANALYTICS, INC.: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 486 MEDEANALYTICS, INC.: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 487 COTIVITI, INC.: COMPANY OVERVIEW
• TABLE 488 COTIVITI, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 489 COTIVITI, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/ UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 490 COTIVITI, INC.: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 491 APIXIO, INC.: COMPANY OVERVIEW
• TABLE 492 APIXIO, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 493 APIXIO, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 494 APIXIO, INC.: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 495 ENLITIC: COMPANY OVERVIEW
• TABLE 496 ENLITIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 497 ENLITIC: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 498 ENLITIC: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 499 KOMODO HEALTH, INC.: COMPANY OVERVIEW
• TABLE 500 KOMODO HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 501 KOMODO HEALTH, INC.: PRODUCT/SOLUTION LAUNCHES/ENHANCEMENTS/APPROVALS/UPGRADES, JANUARY 2021-OCTOBER 2024
• TABLE 502 KOMODO HEALTH, INC.: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 503 HEALTHEC, LLC: COMPANY OVERVIEW
• TABLE 504 HEALTHEC, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 505 HEALTHEC, LLC: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 506 IQVIA: COMPANY OVERVIEW
• TABLE 507 IQVIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 508 IQVIA: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 509 WIPRO: COMPANY OVERVIEW
• TABLE 510 WIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
• TABLE 511 ARCADIA SOLUTIONS, LLC.: COMPANY OVERVIEW
• TABLE 512 EVIDATION HEALTH, INC.: COMPANY OVERVIEW
• TABLE 513 HEALTHCORUM: COMPANY OVERVIEW
• TABLE 514 AETION, INC.: COMPANY OVERVIEW
• TABLE 515 TREDENCE.INC.: COMPANY OVERVIEW
• TABLE 516 SISENSE LTD.: COMPANY OVERVIEW

List of Figures

• FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 HEALTHCARE ANALYTICS MARKET: RESEARCH DESIGN
• FIGURE 3 PRIMARY SOURCES
• FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
• FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
• FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
• FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
• FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION OF OPTUM, INC. (2023)
• FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2024-2029
• FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
• FIGURE 11 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• FIGURE 12 HEALTHCARE ANALYTICS MARKET: DATA TRIANGULATION METHODOLOGY
• FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 HEALTHCARE ANALYTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 HEALTHCARE ANALYTICS MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 HEALTHCARE ANALYTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 17 GEOGRAPHICAL SNAPSHOT OF HEALTHCARE ANALYTICS MARKET
• FIGURE 18 GOVERNMENT INITIATIVES TO INCREASE ELECTRONIC HEALTH RECORD ADOPTION AND INCREASED PRESSURE TO CURB HEALTHCARE COSTS TO PROPEL MARKET
• FIGURE 19 NORTH AMERICA HELD LARGEST SHARE OF HEALTHCARE ANALYTICS MARKET IN 2023
• FIGURE 20 INDIA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
• FIGURE 21 NORTH AMERICA DOMINATED MARKET IN 2023
• FIGURE 22 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
• FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 24 HEALTH EXPENDITURE AS A SHARE OF GDP, 2022 (OR NEAREST YEAR)
• FIGURE 25 HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009-2023
• FIGURE 26 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2009-2023
• FIGURE 27 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN HEALTHCARE ANALYTICS MARKET
• FIGURE 28 HEALTHCARE ANALYTICS MARKET: ECOSYSTEM ANALYSIS
• FIGURE 29 HEALTHCARE ANALYTICS MARKET: VALUE CHAIN ANALYSIS
• FIGURE 30 HEALTHCARE ANALYTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 31 HEALTHCARE ANALYTICS MARKET: PATENT ANALYSIS, JANUARY 2015-SEPTEMBER 2024
• FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USER
• FIGURE 33 KEY BUYING CRITERIA FOR END USER
• FIGURE 35 MARKET POTENTIAL OF AI/GEN AI IN ENHANCING HEALTHCARE ANALYTICS ACROSS INDUSTRIES
• FIGURE 36 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
• FIGURE 37 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT
• FIGURE 38 ASIA PACIFIC: HEALTHCARE ANALYTICS MARKET SNAPSHOT
• FIGURE 39 HEALTHCARE ANALYTICS MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023
• FIGURE 40 HEALTHCARE ANALYTICS MARKET: MARKET SHARE ANALYSIS, 2023
• FIGURE 41 EV/EBITDA OF KEY VENDORS, 2024
• FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF HEALTHCARE ANALYTICS VENDORS, 2024
• FIGURE 43 HEALTHCARE ANALYTICS MARKET: BRAND/SOFTWARE COMPARISON
• FIGURE 44 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 45 HEALTHCARE ANALYTICS MARKET: COMPANY FOOTPRINT
• FIGURE 46 HEALTHCARE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 47 OPTUM, INC: COMPANY SNAPSHOT (2023)
• FIGURE 48 ORACLE: COMPANY SNAPSHOT (2023)
• FIGURE 49 VERADIGM LLC: COMPANY SNAPSHOT (2021)
• FIGURE 50 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2023)
• FIGURE 51 HEALTH CATALYST: COMPANY SNAPSHOT (2023)
• FIGURE 52 CVS HEALTH: COMPANY SNAPSHOT (2021)
• FIGURE 53 MCKESSON CORPORATION: COMPANY SNAPSHOT (2023)
• FIGURE 54 IQVIA: COMPANY SNAPSHOT (2023)
• FIGURE 55 WIPRO: COMPANY SNAPSHOT (2023)